DSM SINOCHEM PHARM NL BV has a total of 231 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets organic fine chemistry, biotechnology and pharmaceuticals are ASYMCHEM LABORATORIES (TIANJIN) CO LTD, ANHUI YOUCARE KAIYUE PHARMACEUTICAL CO LTD and SPOFA SDRUZENI PODNIKUU PRO ZD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 49 | |
#2 | WIPO (World Intellectual Property Organization) | 38 | |
#3 | China | 37 | |
#4 | United States | 26 | |
#5 | Hong Kong | 19 | |
#6 | Mexico | 18 | |
#7 | Israel | 13 | |
#8 | Hungary | 10 | |
#9 | India | 5 | |
#10 | Slovenia | 4 | |
#11 | Brazil | 3 | |
#12 | Canada | 2 | |
#13 | EAPO (Eurasian Patent Organization) | 2 | |
#14 | Republic of Korea | 2 | |
#15 | Singapore | 2 | |
#16 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Biotechnology | |
#3 | Pharmaceuticals | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Fermentation | |
#3 | Peptides | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Enzymes | |
#6 | Therapeutic chemical compounds | |
#7 | Microorganisms | |
#8 | Medical preparations | |
#9 | Measuring microorganism processes | |
#10 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Lange De Ben | 50 |
#2 | Heemskerk Dennis | 46 |
#3 | Elsenberg Henricus Leonardus Marie | 26 |
#4 | Bessembinder Karin Henderika Maria | 26 |
#5 | De Lange Ben | 23 |
#6 | Moody Harold Monro | 20 |
#7 | Pater De Robertus Mattheus | 20 |
#8 | Bovenberg Roelof Ary Lans | 16 |
#9 | Does Van Der Thomas | 15 |
#10 | Tewari Neeraj | 13 |
Publication | Filing date | Title |
---|---|---|
US2019233477A1 | Mbth-like proteins in eukaryotic nrps-catalyzed processes | |
CN107922313A | The salt of dihydro phenyl glycine methyl ester | |
US2018111906A1 | Improved process for preparing a statin precursor | |
WO2016116589A1 | Improved process for preparing statin precursor | |
CA2961698A1 | Salt of phenylglycine methyl ester | |
CN105916680A | Laminated bag for pharmaceuticals | |
US2016215021A1 | Cyclohexapeptide | |
US2016199301A1 | Micronized amoxicillin | |
US2016068564A1 | Method for isolating caspofungin | |
EP2978742A1 | Pharmaceutically acceptable amine salts of pitavastatin | |
MX2015013696A | Amine salts of pitavastatin and rosuvastatin. | |
WO2014154856A1 | Amine salts of pitavastatin and rosuvastatin | |
WO2014044803A1 | Method for producing a cyclic peptide | |
WO2014041059A1 | Process to produce atorvastatin intermediates | |
EP2895459A1 | Process to produce atorvastatin intermediates | |
US2015238425A1 | Mini-tablets | |
WO2014012849A1 | A new crystal form of cefoperazone sodium | |
US2014349340A1 | Mbth-like proteins in the production of semi synthetic antibiotics | |
CN104145021A | Cyclopeptide fermentation at increased metal ion concentration | |
WO2013083718A1 | Process for the preparation of a statin precursor |